CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

BlueCross BlueShield of Wyoming

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
A
Index (ASP = 100)
132.3
Vs. acquisition
+28.8%
Brand index
130.8
Biosimilar index
210.1
Contract variability
Low
Drugs observed
911
States
7

Contracts above the typical acquisition benchmark (102.7) on the median drug.

Thin book — treat these figures as indicative, not comparable.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.